Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment

Run Yu MD, PhD
{"title":"Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment","authors":"Run Yu MD, PhD","doi":"10.1016/j.aace.2024.07.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Objective</h3><p>Extreme hypercortisolemia in an otherwise healthy patient can be due to familial dysalbuminemia, generalized glucocorticoid resistance, and estrogen-containing medications. I report a woman who appeared to have an exaggerated increase in the serum cortisol level following oral contraceptive treatment.</p></div><div><h3>Case Report</h3><p>A 50-year-old woman presented with extreme morning hypercortisolemia—cortisol levels of 61 and 55 mcg/dL (4 and 3 months before presentation, respectively; normal range, 8-25 mcg/dL)—found during workup of mildly increased white cell counts. The morning cortisol level had been 10 mcg/dL after administration of 1-mg dexamethasone. The 24-hour urine free cortisol level had been normal and only slightly increased after correction by creatinine. The patient was anxious about the extremely high cortisol levels but otherwise felt well. She took norgestimate-ethinyl estradiol contraceptive (0.18/0.215/0.25 mg - 35 mcg). Physical examination showed a well-appearing, lean female. The thyroid-stimulating hormone, total thyroxine, free thyroxine, total triiodothyronine, free triiodothyronine, androstenedione, dehydroepiandrosterone sulfate, aldosterone, and renin levels were normal. Morning total cortisol and cortisol-binding globulin (CBG) were tested before and after she held the oral contraceptive for 2 months. The total cortisol and CBG levels decreased from 50 to 26 mcg/dL and from 6.4 to 3.8 mg/dL (normal range, 1.7-3.1 mg/dL), respectively.</p></div><div><h3>Discussion</h3><p>Increases in the serum cortisol-binding proteins are a well-recognized cause for increases in the serum cortisol levels.</p></div><div><h3>Conclusion</h3><p>This case suggests that modern oral contraceptives with low to moderate estrogen activity can cause extreme increases in the serum cortisol levels due to marked increases in the CBG levels.</p></div>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 5","pages":"Pages 206-209"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060524000695/pdfft?md5=fba0152c4327720221c97af6f9b51aae&pid=1-s2.0-S2376060524000695-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AACE Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2376060524000695","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objective

Extreme hypercortisolemia in an otherwise healthy patient can be due to familial dysalbuminemia, generalized glucocorticoid resistance, and estrogen-containing medications. I report a woman who appeared to have an exaggerated increase in the serum cortisol level following oral contraceptive treatment.

Case Report

A 50-year-old woman presented with extreme morning hypercortisolemia—cortisol levels of 61 and 55 mcg/dL (4 and 3 months before presentation, respectively; normal range, 8-25 mcg/dL)—found during workup of mildly increased white cell counts. The morning cortisol level had been 10 mcg/dL after administration of 1-mg dexamethasone. The 24-hour urine free cortisol level had been normal and only slightly increased after correction by creatinine. The patient was anxious about the extremely high cortisol levels but otherwise felt well. She took norgestimate-ethinyl estradiol contraceptive (0.18/0.215/0.25 mg - 35 mcg). Physical examination showed a well-appearing, lean female. The thyroid-stimulating hormone, total thyroxine, free thyroxine, total triiodothyronine, free triiodothyronine, androstenedione, dehydroepiandrosterone sulfate, aldosterone, and renin levels were normal. Morning total cortisol and cortisol-binding globulin (CBG) were tested before and after she held the oral contraceptive for 2 months. The total cortisol and CBG levels decreased from 50 to 26 mcg/dL and from 6.4 to 3.8 mg/dL (normal range, 1.7-3.1 mg/dL), respectively.

Discussion

Increases in the serum cortisol-binding proteins are a well-recognized cause for increases in the serum cortisol levels.

Conclusion

This case suggests that modern oral contraceptives with low to moderate estrogen activity can cause extreme increases in the serum cortisol levels due to marked increases in the CBG levels.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一名妇女口服避孕药后血清皮质醇的过度升高
背景/目的原本健康的患者出现极度高皮质醇血症可能是由于家族性白蛋白血症、全身性糖皮质激素抵抗和含有雌激素的药物所致。病例报告 一位 50 岁的女性患者在接受口服避孕药治疗后出现血清皮质醇水平的夸张性升高--皮质醇水平分别为 61 和 55 mcg/dL(发病前 4 个月和 3 个月;正常范围为 8-25 mcg/dL)--这是在白细胞计数轻度升高的检查中发现的。在服用1毫克地塞米松后,晨间皮质醇水平为10微克/分升。24 小时尿液游离皮质醇水平正常,经肌酐校正后仅略有升高。患者对皮质醇水平过高感到焦虑,但其他方面感觉良好。她服用了炔诺酮-乙炔雌二醇避孕药(0.18/0.215/0.25 毫克 - 35 微克)。体格检查显示,她是一名面容姣好的瘦弱女性。促甲状腺激素、总甲状腺素、游离甲状腺素、总三碘甲状腺原氨酸、游离三碘甲状腺原氨酸、雄烯二酮、硫酸脱氢表雄酮、醛固酮和肾素水平正常。在她口服避孕药 2 个月之前和之后,检测了晨间总皮质醇和皮质醇结合球蛋白(CBG)。总皮质醇和 CBG 水平分别从 50 毫微克/分升降至 26 毫微克/分升,从 6.4 毫克/分升降至 3.8 毫克/分升(正常范围为 1.7-3.1 毫克/分升)。讨论血清皮质醇结合蛋白的增加是导致血清皮质醇水平升高的公认原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
AACE Clinical Case Reports
AACE Clinical Case Reports Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.30
自引率
0.00%
发文量
61
审稿时长
55 days
期刊最新文献
Tongue Bumps as a Manifestation of Underlying Endocrine Neoplasia Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma Uremic Leontiasis Ossea due to Resistant Secondary Hyperparathyroidism A Case of Severe Cushing Syndrome due to Metastatic Adrenocortical Carcinoma Treated With Osilodrostat A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1